IGC Pharma, Inc.
IGC
$0.4514
$0.061415.74%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.34M | -7.12M | -8.81M | -12.57M | -13.30M |
| Total Depreciation and Amortization | 597.00K | 618.00K | 628.00K | 631.00K | 644.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.81M | 1.78M | 1.69M | 5.21M | 5.37M |
| Change in Net Operating Assets | -511.00K | -72.00K | 1.90M | 1.87M | 1.81M |
| Cash from Operations | -4.45M | -4.80M | -4.59M | -4.86M | -5.48M |
| Capital Expenditure | -82.00K | -112.00K | -109.00K | -150.00K | -156.00K |
| Sale of Property, Plant, and Equipment | 742.00K | 40.00K | 18.00K | 18.00K | 1.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -391.00K | -370.00K | -532.00K | -448.00K | -288.00K |
| Cash from Investing | 269.00K | -442.00K | -623.00K | -580.00K | -443.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.00K | -3.00K | -3.00K | -3.00K | -3.00K |
| Issuance of Common Stock | 2.80M | 4.45M | 4.32M | 3.97M | 6.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.80M | 4.45M | 4.31M | 3.97M | 6.03M |
| Foreign Exchange rate Adjustments | 16.00K | -7.00K | -7.00K | -6.00K | -5.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.37M | -793.00K | -908.00K | -1.48M | 101.00K |